Company

PT Kalbe Genexine Biologics

As of the edition of 20 October 2026, PT Kalbe Genexine Biologics runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Stopped1
Total2

Where its trials are

  • Infections: 1 trials led
  • Lungs and airways: 1 trials led